Perry Andrew

Chief Commercial Officer at G1 Therapeutics, Inc.

Sold, on record
$55k
Dollars the filings state
Form 4 sales
5
Latest Jul 5, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

1
Routine
1
Plan not stated
2
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Jan 4, 2023 2023

    Sold 820 shares at $5.58 ($5k)

    Perry Andrew, Chief Commercial Officer

    Sold 3.7% of holdings ($123k position)21,300 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale G1 Therapeutics, Inc.Routine
    Jul 5, 2023 +182 days

    Sold 355 shares at $2.45 ($870)

    Perry Andrew, Chief Commercial Officer

    10b5-1 planSold 0.6% of holdings ($138k position)55,945 shares leftFiling

  3. 3 Form 4 sale G1 Therapeutics, Inc.No plan
    Jan 3, 2024 +182 days

    Sold 2,413 shares at $3.12 ($8k)

    Perry Andrew, Chief Commercial Officer

    No 10b5-1 planSold 2.7% of holdings ($279k position)87,102 shares leftFiling

  4. 4 Form 4 sale G1 Therapeutics, Inc.Unusual
    May 13, 2024 +131 days

    Sold 8,151 shares at $4.79 ($39k)

    Perry Andrew, Chief Commercial Officer

    No 10b5-1 planSold 9.4% of holdings ($417k position)78,951 shares left9.9x usual sizeFiling

  5. 5 Form 4 sale G1 Therapeutics, Inc.No plan
    Jul 5, 2024 +53 days

    Sold 1,337 shares at $2.51 ($3k)

    Perry Andrew, Chief Commercial Officer

    No 10b5-1 planSold 1.2% of holdings ($286k position)112,614 shares left0.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Perry Andrew
Source
Jul 5, 2024Jul 8, 2024G1 Therapeutics, Inc.Chief Commercial OfficerForm 4 sale1,337$3k1.2%No planSEC
May 13, 2024May 15, 2024G1 Therapeutics, Inc.Chief Commercial OfficerForm 4 sale8,151$39k9.4%UnusualSEC
Jan 3, 2024Jan 8, 2024G1 Therapeutics, Inc.Chief Commercial OfficerForm 4 sale2,413$8k2.7%No planSEC
Jul 5, 2023Jul 7, 2023G1 Therapeutics, Inc.Chief Commercial OfficerForm 4 sale355$8700.6%RoutineSEC
Jan 4, 2023Jan 5, 2023G1 Therapeutics, Inc.Chief Commercial OfficerForm 4 sale820$5k3.7%Plan not statedSEC